O-serogroups of multi-drug resistant cervicovaginal Escherichia coli harboring a battery of virulence genes

J Infect Chemother. 2019 Jul;25(7):494-497. doi: 10.1016/j.jiac.2019.02.004. Epub 2019 Feb 26.

Abstract

Multi-drug resistant cervicovaginal Escherichia coli (CVEC) infections are a serious health problem. The aim of this study is to determine the patterns of virulence genes, antibiotic resistance and O-serogroups of CVEC isolated in Mexico. Two hundred strains of CVEC were isolated from women attending two Clinics at the Instituto Mexicano del Seguro Social. E. coli O-serogroups and virulence markers were identified by PCR. Antibiotic susceptibility was determined using the Kirby-Bauer disc-diffusion method. Serogroups O25 (50%), O75 (9%) and O15 (7.5%) were the most frequent among the CVEC strains isolated. The frequencies for antibiotic resistance were ampicillin 97%, (n = 194); carbenicillin 93.5%, (n = 187); cefalotin 77%, (n = 154); and nitrofurantoin 71%, (n = 142). The frequency of multiresistant isolates (3-12 drugs) was 197 (98.5%). The most frequent virulence genes found were feoB (91.5%), fimH (89.5%), kpsMT11 (75%), iutA (66%), and iroN (59%). One hundred and four distinct patterns of virulence markers with antibiotic-resistance genes associated with O-serogroups were identified amongst CVEC isolates. In conclusion: most CVEC strains isolated were multiresistant to antibiotics, belonged to three O-serogroups, and possessed a battery of virulence factors. This knowledge may lead to improved guidelines and standards for treating cervicovaginal infections.

Keywords: Cervicovaginal Escherichia coli; Multidrug-resistance; Virulence markers.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Disk Diffusion Antimicrobial Tests
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Proteins / genetics
  • Female
  • Genotype
  • Humans
  • Mexico
  • Middle Aged
  • Serogroup
  • Uropathogenic Escherichia coli / genetics*
  • Uropathogenic Escherichia coli / isolation & purification
  • Uropathogenic Escherichia coli / pathogenicity
  • Vagina / microbiology
  • Vaginosis, Bacterial / drug therapy
  • Vaginosis, Bacterial / microbiology*
  • Virulence Factors / genetics
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Escherichia coli Proteins
  • Virulence Factors